Age-related Macular Degeneration: Poised for a New Treatment Era
American Academy of Ophthalmology (AAO)The American Academy of Ophthalmology is highlighting what the next decade may hold for the 11 million Americans suffering from AMD.
The American Academy of Ophthalmology is highlighting what the next decade may hold for the 11 million Americans suffering from AMD.
The finding could lead to new ways to prevent cold sores and herpes-related eye disease from reoccurring, the researchers report.
Researchers at the University of Illinois Chicago have been awarded a five-year, $10.15 million grant to develop a broad-spectrum immunomodulatory eye drop.
Patients with age-related macular degeneration (AMD) who become infected with SARS-CoV-2, the virus that causes COVID-19, are at higher risk of developing severe complications including requiring supplemental oxygen and death.
A University of Utah Health ophthalmologist is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
For his research project studying neuroprotection in glaucoma, Pete Williams, PhD from the Karolinska Institutet in Stockholm was awarded the 2021 Shaffer Prize for Innovative Glaucoma Research.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. In data released in preprint, two AAVCOVID vaccine candidates led to robust neutralizing antibody responses in mouse and nonhuman primate models from only a single dose. The candidates were also shown to be safe and well-tolerated in both models.
Scientists at the National Eye Institute (NEI) have developed a promising gene therapy strategy for a rare disease that causes severe vision loss in childhood. A form of Leber congenital amaurosis, the disease is caused by autosomal-dominant mutations in the CRX gene, which are challenging to treat with gene therapy.
New research demonstrates that hypnosis—the process of focusing a person’s attention on a specific task or sensation—can turn a normally difficult visual task into a far easier one by helping individuals mentally “fill in the gaps” of missing visual cues.
Less than twenty years ago, most people diagnosed with advanced age-related macular degeneration (AMD) were destined to become legally blind. Today, advances in the diagnosis and treatment of AMD made possible by retina specialists allow many patients with advanced AMD to keep reading, driving and enjoying their independence.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist, by annually awarding up to three $12,000 awards to young investigators working in areas of translational research. The 2021 awardee is Alex Huang, MD, PhD of the Doheny Eye Institute and University of California in Los Angeles.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals. The award, funded through the ARVO Foundation, supports an early career investigator with a one-year grant of $45,000 to study an aspect of uveitis or other inflammatory conditions of the eye. The 2021 awardee is Shilpa Kodati, MD of the National Eye Institute (NEI) at the National Institutes of Health (NIH).
Dr. Mary Beth Cunnane, a radiologist who specializes in the imaging of patients with diseases of the eyes, ears, nose and head and neck, has been appointed Chief of Radiology at Mass Eye and Ear in Boston.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Dr. David L. Epstein Award. Jamie Craig, MBBS, FRANZCO, DPhil and Owen Siggs, MD, DPhil, are the recipients of the $100,000 award which is funded through the ARVO Foundation.
The latest episode of “On Tech and Vision with Dr. Cal Roberts” centers on the place where big ideas are born – the human brain. The host, Calvin W. Roberts, MD, President and CEO of Lighthouse Guild, explores theories of brain plasticity, sensory substitution, and sensory augmentation with his guests Dr. Patricia Grant, Director of Clinical Research at Wicab Inc., and Dr. John-Ross Rizzo, Director of Innovation and Technology and Assistant Professor in the Department of Rehabilitation Medicine and the Department of Neurology, NYU Langone Medical Center.
The Catalyst Award will be presented to Ramin Valian of Allergan, an AbbVie Company, in recognition of Allergan's ongoing leadership and commitment to the development of innovative treatments to advance glaucoma care.
Retinal cells derived from a cadaver human eye survived when transplanted into the eyes of primate models, an important advance in the development of cell therapy to treat blindness, according to a study published on January 14 in Stem Cell Reports.
In experiments in mouse tissues and human cells, Johns Hopkins Medicine researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases. The findings are specifically aimed at discovering new ways to reverse vision loss caused by glaucoma and other diseases that affect the optic nerve, the information highway from the eye to the brain.
What if the degenerative eye conditions that lead to glaucoma, corneal dystrophy, and cataracts could be detected and treated before vision is impaired? Recent findings from the lab of Investigator Ting Xie, PhD, at the Stowers Institute for Medical Research point to the ciliary body as a key to unlocking this possibility.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Roche Collaborative Research Fellowships. Wanjiku Mathenge MBChB, MMed, MSc, PhD, Sudhir H Ranganath, PhD, and Pablo Federico Barcelona, PhD, are the recipients of the fellowships that are generously funded by F. Hoffmann-La Roche Ltd., through the ARVO Foundation.